» Articles » PMID: 9395587

Why Are African Americans Under-represented in Medical Research Studies? Impediments to Participation

Overview
Journal Ethn Health
Publisher Informa Healthcare
Date 1997 Mar 1
PMID 9395587
Citations 164
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: In accordance with the NIH Revitalization Act of 1993, the National Institutes of Health and the Alcohol, Drug and Mental Health Administration require grant applicants and cooperative agreement participants to include minorities in human subject research. In an environment characterized by diminishing research dollars, this mandate has increased the pressure on investigators to determine factors that impede minority participation and to develop strategies to overcome these impediments.

Methods: An extensive review of the literature was conducted to identify the factors possibly responsible for the low participation levels of African Americans in medical research studies and to highlight areas for further research. The items examined included the historical relationship between African Americans and medical researchers and the attitudes, perceptions and beliefs of potential participants and researchers as they relate to the low representation of African Americans in medical research.

Results: The factors identified as possible impediments to African American participation included distrust of the medical/scientific community, poor access to primary medical care, the failure of researchers to recruit African Americans actively, the alienation of minority health professionals, lack of knowledge about clinical trials, language and cultural barriers.

Conclusions: Well-designed, relevant, ethical research in conjunction with an appreciation of the many barriers to participation are paramount to increasing African American presence in clinical research.

Citing Articles

Black community member perceptions and ethics recommendations on epigenomic research.

Berrios C, Basey T, Bradley-Ewing A, Daniels-Young S, Lewis D, Feldman K Clin Epigenetics. 2025; 17(1):33.

PMID: 39987106 PMC: 11847333. DOI: 10.1186/s13148-025-01840-0.


Reporting and representation of participant race and ethnicity in phase III clinical trials for solid tumors.

Wang T, Villanueva D, Banerjee A, Gifkins D Future Sci OA. 2025; 11(1):2458415.

PMID: 39885684 PMC: 11792851. DOI: 10.1080/20565623.2025.2458415.


Operationalising routinely collected patient data in research to further the pursuit of social justice and health equity: a team-based scoping review.

Chadd K, Caute A, Pettican A, Enderby P BMC Med Res Methodol. 2025; 25(1):14.

PMID: 39838312 PMC: 11749527. DOI: 10.1186/s12874-025-02466-9.


Unlocking Diversity in Cardiovascular Clinical Research: Lessons from the Screening for Cardiac Amyloidosis With Nuclear Imaging in a Minority Populations Study.

Wardhere A, Bampatsias D, Cohn E, Fine D, de Freitas C, Gallegos C J Card Fail. 2024; 30(11):1507-1511.

PMID: 38740174 PMC: 11551251. DOI: 10.1016/j.cardfail.2024.04.019.


"Lord Knows What's Being Done with My Blood!": Black Women's Perceptions of Biospecimen Donation for Clinical Research in the United States.

Brown K, Thomas S, Brothers R, Liao Y J Racial Ethn Health Disparities. 2024; .

PMID: 38714639 DOI: 10.1007/s40615-024-02015-y.